GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » Equity-to-Asset

US Neurosurgical Holding (US Neurosurgical Holding) Equity-to-Asset : 0.49 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. US Neurosurgical Holding's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.65 Mil. US Neurosurgical Holding's Total Assets for the quarter that ended in Dec. 2023 was $1.32 Mil.

The historical rank and industry rank for US Neurosurgical Holding's Equity-to-Asset or its related term are showing as below:

USNU' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26   Med: 0.49   Max: 0.88
Current: 0.49

During the past 13 years, the highest Equity to Asset Ratio of US Neurosurgical Holding was 0.88. The lowest was 0.26. And the median was 0.49.

USNU's Equity-to-Asset is ranked better than
52.89% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs USNU: 0.49

US Neurosurgical Holding Equity-to-Asset Historical Data

The historical data trend for US Neurosurgical Holding's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding Equity-to-Asset Chart

US Neurosurgical Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.88 0.70 0.71 0.49

US Neurosurgical Holding Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.71 0.69 0.65 0.49

Competitive Comparison of US Neurosurgical Holding's Equity-to-Asset

For the Medical Care Facilities subindustry, US Neurosurgical Holding's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


US Neurosurgical Holding's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where US Neurosurgical Holding's Equity-to-Asset falls into.



US Neurosurgical Holding Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

US Neurosurgical Holding's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.645/1.321
=

US Neurosurgical Holding's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.645/1.321
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Neurosurgical Holding  (OTCPK:USNU) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


US Neurosurgical Holding Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850
US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.
Executives
Lawrence William St director 23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler director 43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii director
Alan Gold director, 10 percent owner, officer: President & Chairman 2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman 10 percent owner C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc 10 percent owner 711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines